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Abstract 
Background: The egg is a vital part of the chicken developmental process and an important protein source for 
humans. Despite the chicken egg being a subject of intense research little attention has been given to the role of 
microRNAs within the egg.
Findings: We report a method for the reproducible and reliable isolation of miRNA from the albumen and yolk of 
chicken eggs. We also report the detection via real-time PCR of a number of miRNAs from both of these biological 
fluids.
Conclusions: These findings provide an interesting look into the chicken egg and raise questions as to the role that 
miRNAs maybe playing in the chicken egg. This method of detecting miRNAs in chicken eggs will allow researchers to 
investigate the presence of an additional level of epigenetic programming in chick development previously unknown 
and also how this impacts the nutritional value of eggs for human consumption.
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Findings
Background
Eukaryotic multicellular life has evolved a variety of tech-
niques in order to nourish the developing young both 
before and after birth, these techniques include nourish-
ment via the placenta, the avian and reptilian egg and 
mammalian lactation. Whilst the primary function of 
these various adaptations is nutrition they also aid devel-
opment through the delivery of bioactive molecules such 
as hormones [1, 2], antibodies [3, 4] and, in the case of 
mammalian milk, through the delivery of microRNAs 
(miRNA) [5].
These miRNAs are a small non-coding species of RNA 
found in eukaryotic cells that play an important role in 
gene regulation and are involved in a diverse variety of 
biological processes [6]. These regulatory molecules are 
found in a number of biological fluids including blood, 
milk and saliva [7, 5, 8]. There is evidence that the poul-
try egg packages bioactive molecules, such as hormones 
and antibodies, which play an important role in the epi-
genetic development of the chick [9–11].
Despite a number of studies having profiled miRNA 
expression in the developing chicken embryo [12], to 
our knowledge, no-one has yet described the presence 
of miRNA in either the albumen (white) or yolk of the 
chicken egg. In this study we describe a method for reli-
ably and reproducibly extracting miRNA from both the 
albumen and yolk of unembryonated chicken eggs. We 
go on to screen the extracted RNA for the presence of 21 
miRNAs via reverse transcription quantitative real-time 
PCR (RT-qPCR). Of these 21 miRNAs, ten were selected 
as they had previously been described to be present in 
the developing chick [12–14], a further ten were selected 
as they have been found to be expressed in chicken tis-
sue from unrelated work in our lab (unpublished) and a 
housekeeping putative miRNA. Following detection of 
miRNA in both albumen and yolk we analyse the expres-
sion pattern of five of these microRNAs in greater detail 
and show differences between the yolk and albumen in 
respect to the levels of specific miRNAs.
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Methods
Extraction of miRNA from albumen
Reagents, unless otherwise indicated, were those sup-
plied with the Exiqon© miRCURY™ biofluid RNA isola-
tion kit for both the albumen and yolk extractions. Initial 
extractions were checked for purity for both the albumen 
and yolk extractions by analysing the absorbance ration 
A260/A280 and were all found to be >1.9. Albumen from 
two commercial unembryonated cage-laid eggs were 
homogenised by vortexing and 200  µl of homogenate 
was then diluted in lysis solution BF at a 1:1 ratio, vor-
texed thoroughly and incubated at room temperature for 
15 min. Fifty units of proteinase K (Promega), at a con-
centration of 10,000 units per ml in sterile distilled H2O, 
was added and the solution vortexed and incubated at 
37 °C for 10 min. The solution was centrifuged at 3000g 
for 5  min. The clear supernatants was transferred to a 
new 1.5 ml microcentrifuge tube and to this 40 µl of pro-
tein precipitation solution BF was added and mixed by 
vortexing followed by incubation at room temperature 
for 1  min. The solution was then centrifuged for 3  min 
at 11,000g. After this the extraction continues as per the 
Exiqon© miRCURY™ biofluid RNA isolation kit standard 
instructions from step 4 onwards.
Extraction of miRNA from yolk
Yolk from two commercial unembryonated cage-
laid eggs were homogenised by vortexing and 1  ml of 
homogenate was then diluted in lysis solution BF at a 
1:1 ratio, vortexed thoroughly and incubated at room 
temperature for 15  min. 400  µl aliquots of the yolk/
lysis solution was dispensed into five 1.5  ml micro-
centrifuge tubes. To each of these aliquots 600  µl of 
Cleanascite™ was added followed by rigorous vortex-
ing until the sample became homogenous. The Clean-
ascite™ removes the lipid from this high fat tissue that 
would otherwise interfere with the extraction process. 
The ratio of Cleanscite™:yolk is 3:1 (taking into account 
that the yolk has been diluted in an equal volume of 
lysis solution BF). During optimisation of this proce-
dure ratios of Cleanascite™:yolk between 1:1 and 1:10 
were performed with 1:3 being found to give the best 
balance between yield and purity. Solutions were then 
incubated at 4  °C for 1  h. After incubation samples 
were centrifuged at 13,000g for 5  min. Clear superna-
tant was transferred to a new 1.5  ml microcentrifuge 
tube and to this 40 µl of protein precipitation solution 
BF was added. The solution was mixed by vortexing fol-
lowed by incubation at room temperature for 1 min and 
then centrifugation for 3 min at 11,000g. After this the 
extraction continues as per the Exiqon© miRCURY™ 
biofluid RNA isolation kit standard instructions from 
step 4 onwards.
RT‑qPCR of miRNA from extracted RNA
The miRNA was quantified using the Qubit® MicroRNA 
Assay Kit on a Qubit® 3.0 Fluorometer using software 
APP v1.02 + MCU v0.21. Primers and probes were pur-
chased from Applied Biosystems™ from their TaqMan® 
MicroRNA assay range, manufactures probe name and 
the name of the equivalent published chicken miRNA, 
when applicable, (as per mirBase Release 21) can be 
found in Table 1 along with the sequence of the house-
keeping gga-mir-control.
The method of producing the miRNA pools subse-
quently used in the RT-qPCR analysis is shown in Fig. 1. 
The rationale behind this method was firstly to show that 
the method worked consistently in extracting miRNA 
(total of 18 extractions from either fluid) and secondly, 
by pooling the extractions, to demonstrate reproducibil-
ity by minimising the potential impact of any single egg 
with a radically different miRNA profile from the oth-
ers. Briefly the yolk and albumen of two eggs are sepa-
rated and the two yolks and two albumen homogenised 
together, this is done three times to produce three bio-
logically distinct homogenates. From each homogenate 
three independent extractions were performed and one 
extraction from each homogenate are combined in equal 
Table 1 TaqMan® probes used in this study




hsa-mir-10a gga-mir-10a-5p – –
hsa-mir-10b gga-mir-10b-5p – –
hsa-mir-22 gga-mir-22-3p – –
hsa-mir-26a gga-mir-26a-5p – –
hsa-mir-30c gga-mir-30c-5p + +
hsa-mir-30c-1 No published equivalent – –
gga-mir-30c-1-3p n/a – –
hsa-mir-92a gga-mir-92-3p + +
hsa-mir-99a gga-mir-99a-5p + –
hsa-mir-100 gga-mir-100-5p + –
mmu-mir-142-3p gga-mir-142-3p + –
gga-mir-146c n/a – –
hsa-mir-183 gga-mir-183 – –
hsa-mir-204 gga-mir-204 – –
hsa-mir-215 gga-mir-215-5p + +
hsa-mir-486-3p No published equivalent – –
oan-mir-1388-5p No published equivalent – –
gga-mir-2188 n/a + +
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quantities to generate the three pools. This protocol was 
performed in duplicate.
10 ng of pooled miRNA was used in a 15  µl compli-
mentary DNA (cDNA) synthesis reaction using the 
Taqman® microRNA reverse transcription kit (Applied 
Biosystems™) as per manufacturer’s instructions in con-
junction with the appropriate primers, no more than six 
miRNAs were amplified in a given cDNA reaction. The 
RT-qPCR reactions were formulated as per manufactur-
er’s instructions using 1 µl of the above cDNA per 15 µl 
reaction and using Taqman® universal master mix II, no 
UNG (Applied Biosystems™). RT-qPCR was undertaken 
on a Bio-Rad C1000 thermal cycler with CFX96 real-time 
system with the following protocol; 10 min at 95 °C fol-
lowed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min 
with fluorescence being read at the end of the 60 °C step. 
Acquisition and analysis of data was undertaken using 
the software BioRad CFX manager version 3.0.1215.0601. 
Ct values were recorded at a relative fluorescent unit 
value of 20,000. Expression levels were calculated rela-
tive to gga-mir-control where the average expression of 
gga-mir-control across the yolk pools was given an arbi-
trary expression value of 1000. Each of the 6  gga-mir-
control values for both tissue were then scaled against 
the average across the yolk pools allowing normalisation 
against the control within each sample.
Statistical analysis was undertaken using SPSS version 
23. Statistical significance was calculated using One-Way 
ANOVA with Tukey Post Hoc test.
Results and discussions
MiRNA can be extracted and detected from albumen 
and yolk
This is the first report of the extraction of miRNA from 
the albumen and yolk of chicken eggs. One reason why 
this may not have been attempted before could be the 
difficulties presented by the composition of these two 
tissues; with yolk being lipid rich and albumen high in 
protein. We overcame these potential problems by pro-
teinase K treatment of the albumen and Cleanascite™ 
treatment, which binds and removes lipids from samples, 
of the yolk.
Fig. 1 Protocol for the generation of pooled miRNA. A flow-diagram detailing the generation of the pooled miRNA used for cDNA synthesis. A total 
of nine extractions from three biologically distinct homogenates (comprising of either the albumen or yolk of two eggs) is used to produce the 
three pools. The protocol is repeated in duplicate
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Eighteen independent extractions were undertaken 
from the albumen and yolk of commercial cage-laid 
eggs. The extractions were quantified using a miRNA 
specific quantification assay and water only extractions 
were included as negative controls. Albumen extractions 
ranged in concentration from 72 to 2.21 ng/µl in a total 
volume of 50  µl making for a total yield of between 3.6 
and 110.5 ng of miRNA from 200 µl of starting albumen 
with an average concentration of 595 pg/µl (average total 
yield of 29.75 ng). The concentration of the yolk extrac-
tions was between 243 pg/µl and 5.37 ng/µl in a total of 
50 µl making for a yield of between 12.15 and 268.5 ng of 
miRNA from 1 ml of starting yolk giving an average con-
centration of 2.33 ng/µl (average total yield of 116.5 ng). 
In all cases the water only negative control did not regis-
ter as containing miRNA in the quantification assay.
To confirm that these concentrations translated to 
detectable miRNA and to demonstrate that such extrac-
tions were suitable for downstream application we chose 
to perform RT-qPCR using cDNA generated from the 
six pools (see Fig.  1) of miRNA for each fluid against a 
suite of 21 target miRNAs. Initially all 21 targets were 
investigated in just a single albumen and yolk pool before 
performing a more targeted investigation. A miRNA 
was considered ‘present’ if it was detected prior to the 
35th cycle in the RT-qPCR run. Although signal could 
be detected for some probes beyond cycle 35 the signal 
tended to be inconsistent with large differences between 
technical duplicates and were considered generally unre-
liable so an exclusive rather than inclusive approach was 
taken. Results are shown in Table 1. Of the 21 miRNAs 
screened for eight were present in yolk and five in albu-
men. The five present in albumen were all present in yolk.
Four targets and two controls were chosen for expres-
sion analysis across all pools. These were gga-mir-control, 
as an endogenous positive control and for calculating 
relative expression; gga-mir-183, which was not present 
in either fluid, as an endogenous negative control; gga-
mir-2188, gga-mir-30c-5p, gga-mir-215-5p and gga-mir-
92-3p all of which were present in both fluids. Results of 
the analysis are shown in Fig. 2. All miRNAs previously 
detected in both fluids were found to be consistently pre-
sent and gga-mir-183 was not detected in any sample. 
The relative expression of gga-mir-2188, gga-mir-30c-5p 
and gga-mir-92-3p was significantly (p < 0.01) higher in 
yolk than in albumen.
This is the first study to report the isolation and detec-
tion of miRNAs in either chicken egg albumen or yolk. 
This observation means that chicken egg albumen and 
yolk join mammalian milk [5] as being a nutritive sub-
stance which also carries miRNAs. The methods of 
extraction reported here will be of value to both veteri-
nary and miRNA researchers particularly in respect to 
those with an interest in the epigenetic factors that influ-
ence livestock production.
It is interesting to note that seven of the eight miR-
NAs detected within the egg, all have either been pre-
viously reported to be expressed in embryos or have 
been directly implicated in embryo development. The 
equivalent namesake mouse and zebrafish miRNAs of 
gga-mir-2188, gga-mir-99a-5p and gga-mir-142-3p have 
been shown to be involved in the development of the vas-
cular system and hematopoiesis in the embryos of mice 
and zebrafish [15–17]. The mir-30 family of miRNAs 
have been shown to be involved in early muscle develop-
ment in zebrafish [18] and the mouse equivalent (mmu-
mir-100-5p) of gga-mir-100-5p is involved in embryonic 
stem-cell differentiation [19]. Whilst in humans hsa-mir-
99a and hsa-mir-92a are necessary for correct embryo 
development [20, 21]. Finally in pigs ssc-mir-215-5p has 
been reported to be present in the head and organs of 
33  day old embryos. Of the seven miRNAs three; gga-
mir-30c-5p, gga-mir-99a-5p and gga-mir-100-5p have 
been reported to be present within chicken embryos [14].
It is possible that the presence of miRNA in the egg is 
simply a by-product of egg development/maintenance 
and reflects the processes involved therein and are not 
actually playing a role in chick development per se. Argu-
ing against this though is the fact that albumen and yolk 
of unembryonated eggs display very low levels of meta-
bolic activity [22, 23] and as such would be unlikely to be 
producing large amounts of miRNA. Given our obser-
vation of the presence of seven miRNAs within the egg 
that have either been implicated in embryo develop-
ment or shown to be expressed in embryos of chickens 
and other species it would seem more likely that at least 
some of the miRNAs in these fluids are playing a role in 
embryo development rather than being reflective of more 
general egg processes. Whilst we acknowledge that we 
can only speculate at this point, our miRNA extraction 
method will enable further research to investigate such 
hypotheses.
The discovery of miRNAs in eggs has potentially 
important implications. The active transport of ben-
eficial miRNAs from the mother into the albumen or 
yolk would be an efficient mechanism for the chicken 
to help promote normal chick development as the 
miRNAs could be continually supplied to the grow-
ing embryo during nutrient uptake. If, as we suggest, 
maternally derived miRNAs in the egg are being used 
during chick development then this presents an attrac-
tive manner in which the poultry industry may be able 
to promote better production standards and animal wel-
fare outcomes. The selective inclusions of miRNAs into 
the egg that promote immune system development or 
increased intestinal absorptive efficiency are just two 
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examples of the possible applications of this exciting 
discovery. Another potential outcome of these findings 
could be the improvement of eggs for human consump-
tion by modulating nutritional value or extending their 
shelf-life.
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